Among 3,468 Danish adults aged 45-84 (12% with spirometry-defined COPD), drinking more than 10 units weekly was not linked to 10-year mortality across 593 deaths: unadjusted HR 0.97 (0.80-1.18), fully adjusted HR 0.87 (0.71-1.07). COPD itself roughly doubled death risk (adjusted HR 2.00, 1.64-2.43), independent of comorbidities and lifestyle. No alcohol-by-COPD interaction emerged, and no alcohol-comorbidity associations survived false discovery rate correction.
The null result should be read as an absence of evidence, not a green light. The comparison is crude: a binary cut at 10 units splits mostly moderate drinkers from slightly heavier ones, so it says little about heavy or binge consumption. Baseline-only exposure ignores drinking changes over a decade, and the classic sick-quitter problem, where people with poor health abstain, can mask harm because the reference group may include frail non-drinkers. The authors adjusted for comorbidities that may sit on the causal pathway, which can bias toward the null. With only about 400 COPD participants, the interaction test had limited power. Larger consortia and Mendelian randomization work generally find rising mortality with heavier intake. The practical takeaway for adults with COPD is that the dominant, modifiable drivers remain smoking cessation, exercise and pulmonary rehabilitation, not fine-tuning alcohol intake. Still, alcohol worsens sleep, blood pressure and cancer risk, so this is a confirmatory, underpowered null that changes no advice.